To: freedom-35 who wrote (8610 ) 2/1/2002 12:13:57 AM From: Cal Gary Respond to of 14101 Freedom 3x What a small world, so we are squarely settled on the topic of round symbols, letters and now little red arrows. Its funny you mentioned the little red arrow. In the past 3 days, my wife snuck up behind to see what I was doing. Day 1 "What's that little red arrow? What does it mean?" (She really does know, why did she ask? Give her the academic answer) Honey that is the tick down symbol, it means the last trade in the stock traded at a price that is less than the prior trade. The arrow changes to green on an uptick. "Oh" Day 2 "That little red arrow is still there! How much are we losing?" Day 3 "Sigh" or was it "Hmmm" Hi, ya the little red arrow is still there. ... Look! honey it turned green! Honey! Honey? Where'd you go? It does turn green, really. I wonder if Rebecca could put a good word in for the Stalward investor's wives (or vise versa) during the next CC. ------------------- This is JnJ's prescription and devices roster according to a poster at JnJ Yahoo thread. So many lines with the word, "Billions". Yup, one well lubricated marketing Elephant. BTW, the list doesn't include the OTC consumer products. 1.Procrit=$3.4Billion 2.Levaquin =$1.2 Billion 3.Oral Contraceptives= $1.1Billion 4.Duragesic=$1.1Billion 5.Remicade=$1 Billion 6.Risperdal=$2Billion 7.Ultram/Ultracet=$800-900 Million 8.Cordis=$1.5 Billion 9.DePuy= $2.2 Billion 10.Ethicon=$2.2Billion 11.Ethicon-Endo=$2.2Billion 12.Lifescan=$1.2Million 13.Ortho-Clinical=$1.1Billion 14.Vistakon=$1.1Billion Keep your eyes on no. 7 Ultram. If I recall correctly, JnJ is pumping Big marketing bucks into this next generation "safer" pain killer. It may also have ties with Biovail. I haven't double checked this, so beware.